Table 20 (Abstract P254). See text for description
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part two
Number of patients | 51 |
|---|---|
Girls/Boys | 39/12 |
Age (years) | 13.12 (6.75;16.74) |
DMARD and/or biological medication | 35 |
sJIA, poly RF+, poly RF-, oligo, enthesitis, PsA, Undifferentiated | 10%, 0, 27%, 37%, 4%, 11%, 11% |